EQSNews: leonnanodrugs GmbH
/ Key words: Study results
Technical Evaluation by CMAC Introduces LEON’s CuttingEdge Formulation Technology
11.04.2024 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Revolutionising Nanoparticle Production: Te... Lire le communiqué |
|
|
|
|
EQSNews: leonnanodrugs GmbH
/ Key words: Personnel
leonnanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
18.07.2023 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
leonnanodrugs appoints Dr. Hans Frickel as Chief Executive... Lire le communiqué |
|
|
|
|
EQSNews: leonnanodrugs GmbH
/ Key words: Personnel
leonnanodrugs GmbH: LEON appoints Dr. Setu Kasera as Chief Scientific Officer
16.05.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
LEON appoints Dr. Setu Kasera as Chief Scientific Officer
leonnanodr... Lire le communiqué |
|
|
|
|
EQSNews: leonnanodrugs GmbH
/ Key words: Alliance/Expansion
LEON sets up lab facilities at the Innovation and StartUp Center for Biotechnology IZB in Munich
27.04.2023 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
LEON sets up lab facilities at the Innovation and StartUp... Lire le communiqué |
|
|
|
|
EQSNews: leonnanodrugs GmbH
/ Key words: Research Update
LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles
03.01.2023 / 15:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
LEON successfully completes development of... Lire le communiqué |
|
|
|
|
EQSNews: leonnanodrugs GmbH
/ Key words: Alliance
Harro Höfliger and LEON collaborate to bring the innovative NANOus LNPencapsulation device to market for rapid, largescale prophylactic vaccine manufacturing
26.10.2022 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Har... Lire le communiqué |
|
|
|
|